Sort
64,565 grants matching “drug discovery”
Spontaneous activity in the developing auditory system
$521,955Dwight E Bergles · Johns Hopkins University · R01 · FY2021 · DC
CAREER: Light- and temperature- controlled peptide ligands for purifying blood factors and orphan enzyme drugs
$521,930Stefano Menegatti · North Carolina State University · · FY2017 · ENG
RIDGE: Tipping Points in the Evolution of Submarine Hydrothermal Systems: Habitat Generation, Organic Transformation, and Rock Alteration
$521,875Everett L Shock · Arizona State University · · FY2009 · GEO
Chemical Genetic Approaches to Study Chromatin Complexes
$521,834Brian Liau · Harvard University · R01 · FY2025 · CA
Glial and Synaptic Functions in Major Depression
$521,809Chadi Abdallah · Yale University · R01 · FY2017 · MH
Structure-based targeting of the C. difficile toxin (CDT) from hypervirulent bacterial strains
$521,751David Joseph Weber · University Of Maryland Baltimore · R56 · FY2021 · AI
Hepatic Wnt/LRP6 Regulation of Plasma Lipids
$521,751Arya Mani · Yale University · R01 · FY2016 · HL
Washington University PDX Development and Trial Center
$521,719Ramaswamy Govindan · Washington University · U54 · FY2022 · CA
Drug Discovery for Fatty Acid Synthase in Oncology
$521,711Jeffrey W Smith · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2010 · CA
Hit-to-lead discovery for sleeping sickness via industry-academic partnership
$521,683Michael P Pollastri · Northeastern University · R01 · FY2017 · AI
Defining GATA4âs Molecular Function in Gastric Cell Biology
$521,650Michele A Battle · Medical College Of Wisconsin · R01 · FY2023 · DK
Mcl-1 in apoptosis and signal transduction: a structure/function approach
$521,604Maurizio Pellecchia · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2015 · CA
TARGETING DEFENSES OF MYCOBACTERIUM TUBERCULOSIS
$521,587Weill Medical College Of Cornell Univ · R01 · FY2003 · HL
BCR-ABL Kinase Assays for STI571 Sensitivity of Response
$521,577University Of Chicago · R33 · FY2004 · CA
Drug Discovery and Development
$521,461Paul D. Robbins · Mayo Clinic Rochester · P01 · FY2022 · AG
Scientific and Administrative Management Core
$521,412Nahid Turan · Coriell Institute For Medical Research · U42 · FY2015 · GM
In Vitro and In Situ Engineering of Fibroblasts for Cardiac Repair
$521,375Nenad Bursac · Duke University · R01 · FY2019 · HL
New Non-Nuceleotide Reverse Transcriptase Inhibitors for Drug Resistant HIV Strains
$521,364Chin-Ho Chen · Duke University · R01 · FY2023 · AI
Thrombocytopoiesis in Diabetes: Role of Damage Associated Molecular Patterns
$521,355Prabhakara Reddy Nagareddy · Ohio State University · R01 · FY2020 · HL
Drug Development for MDR-M tuberculosis
$521,318James D Dick · Johns Hopkins University · U01 · FY2007 · AI
Beamline Automation for Structure Determination
$521,300Thomas N Earnest · University Of Calif-Lawrenc Berkeley Lab · R01 · FY2006 · GM
Drug Discovery Group for Nicotine Dependence Treatment
$521,261Maurizio Fava · Massachusetts General Hospital · U01 · FY2008 · DA
Novel Probes for Imaging Beta Cell Mass
$521,178Ralph Weissleder · Harvard Medical School · P01 · FY2013 · AI
Mechanism of Action of Estrogens and Antiestrogens
$521,155Donald P McDonnell · Duke University · R37 · FY2014 · DK
Filling the data processing gap for exon-region specific data from 1000 Genomes
$521,149Richard A Gibbs · Baylor College Of Medicine · U01 · FY2010 · HG